Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
Delayed Quote. Delayed Nyse - 04/03 04:10:00 pm
73.37 USD   -2.34%
04/03ABBVIE : Form 8.3 - -2-
DJ
04/03ABBVIE : Form 8.3 -
DJ
04/02ABBVIE : Form 8.3 - -2-
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/30/2020 03/31/2020 04/01/2020 04/02/2020 04/03/2020 Date
75.24(c) 76.19(c) 73.42(c) 75.13(c) 73.37(c) Last
10 671 563 20 481 986 12 948 010 8 077 758 8 004 612 Volume
+3.54% +1.26% -3.64% +2.33% -2.34% Change
More quotes
Financials (USD)
Sales 2020 35 614 M
EBIT 2020 17 147 M
Net income 2020 10 835 M
Debt 2020 22 541 M
Yield 2020 6,39%
Sales 2021 37 708 M
EBIT 2021 18 426 M
Net income 2021 12 116 M
Debt 2021 16 879 M
Yield 2021 6,84%
P/E ratio 2020 8,25x
P/E ratio 2021 7,58x
EV / Sales2020 3,75x
EV / Sales2021 3,39x
Capitalization 111 B
More Financials
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with... 
Sector
Pharmaceuticals
Calendar
04/14Ex-dividend day for
More about the company
Surperformance© ratings of AbbVie Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE INC.
04/03ABBVIE : Form 8.3 - -2-
DJ
04/03ABBVIE : Form 8.3 -
DJ
04/02ABBVIE : Form 8.3 - -2-
DJ
04/02ABBVIE : Form 8.3 -
DJ
04/02ABBVIE : Form 8.3 -
AQ
04/02ABBVIE : to Host First-Quarter 2020 Earnings Conference Call
PR
04/01ABBVIE : Form 8.3 - -2-
DJ
04/01ABBVIE : Form 8.3 -
DJ
04/01ABBVIE : Form 8.3 -
AQ
03/31ABBVIE : Donates $35 Million for COVID-19 Relief to Support Healthcare Systems, ..
PR
03/31ABBVIE : Form 8.3 - -2-
DJ
03/31ABBVIE : Form 8.3 -
DJ
03/30ALLERGAN : Form 8.3 - -2-
DJ
03/30ABBVIE : Form 8.3 -
DJ
03/27ABBVIE : Form 8.3 - -2-
DJ
More news
News in other languages on ABBVIE INC.
03/18EN DIRECT DES MARCHES : Sodexo, L'Oréal, OSE Immuno, Econocom, Fnac Darty, Te..
03/18STOCK MARKET PARIS : Les Etats répondent présent
03/17Nestlé se rapproche de la reprise du médicament Zenpep d'Allergan
03/17Nestlé ist Übernahme von Allergan-Medikament Zenpep einen Schritt näher
02/10Aktien New York Ausblick: US-Börse nach Gewinnmitnahmen zunächst auf Standby
More news
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 94,79  $
Last Close Price 75,13  $
Spread / Highest target 41,1%
Spread / Average Target 26,2%
Spread / Lowest Target -6,83%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.-17.13%112 508
JOHNSON & JOHNSON-8.02%345 705
ROCHE HOLDING AG2.77%277 060
MERCK & CO., INC-16.16%195 141
NOVARTIS-11.15%187 703
PFIZER, INC.-14.14%181 075